AMP Comments At FDA Meeting On Array-Based Tests
Links shared publicly online about this topic.
- 1,053total visits
AMP Comments At FDA Meeting On Array-Based Tests
View full resource at medicalnewstoday.com
Tags: Genetic, Disease and Condition, Drug, FDA, Pathology
Most Recently Shared on July 1, 2010 at 9:06 pm By:
AMP Comments At FDA Meeting On Array-Based Tests http://mnt.to/3FDb #genetics
Also Shared By:
AMP particpates at FDA's public meeting on oversight of laboratory developed tests
news-medical.net — “The Association for Molecular Pathology participated in the Food and Drug Administration Center for Devices and Radiological Health public meeting on the oversight of laboratory developed tests. Dr. Karen Mann, President of AMP, served on the second panel of the meeting titled, Clinical Laboratory Challenges. Additionally, Dr. Elaine Lyon, Chair of the AMP Professional Relations Committee, presented public comments. "AMP believes that LDTs are an essential and central component of medical p” View full resource at news-medical.net
Most Recently Shared on July 21, 2010 at 12:27 pm By:
News-Medical.Net Health News and Oncology
Oncology News: AMP particpates at FDA's public meeting on oversight of laboratory developed tests: The Association... http://bit.ly/b82vrK
AMP Presents at FDA Meeting on Regulating Diagnostics
newswise.com — “The Association for Molecular Pathology (AMP) participated in the Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) public meeting on the oversight of laboratory developed tests (LDTs). Dr. Karen Mann, President of AMP, served on the second panel of the meeting titled, Clinical Laboratory Challenges. Additionally, Dr. Elaine Lyon, Chair of the AMP Professional Relations Committee, presented public comments.” View full resource at newswise.com
Most Recently Shared on July 20, 2010 at 7:16 pm By:
newswise Health News and Health Communicator
AMP Presents at FDA Meeting on Regulating Diagnostics: The Association for Molecular Pathology (AMP) participated ... http://bit.ly/aIoDdN
AMP comments on array-based cytogenetic tests at FDA's public meeting
news-medical.net — “Today, the Association for Molecular Pathology presented comments at the US Food & Drug Administration's public meeting on array-based cytogenetic tests. The FDA convened the meeting to seek answers to more than a dozen questions they had on how to evaluate the performance, interpret results and report findings of array-based cytogenetic tests for copy number variation.” View full resource at news-medical.net
Most Recently Shared on July 1, 2010 at 4:00 pm By:
AMP comments on array-based cytogenetic tests at FDA's public meeting: Today, the Association for Molecular Pathol... http://bit.ly/dnYqJt
AMP Comments at FDA Meeting on Array-Based Tests
newswise.com — “Today, the Association for Molecular Pathology (AMP) presented comments at the US Food & Drug Administration's public meeting on array-based cytogenetic tests. The FDA convened the meeting to seek answers to more than a dozen questions they had on how to evaluate the performance, interpret results and report findings of array-based cytogenetic tests for copy number variation (CNV).” View full resource at newswise.com
Most Recently Shared on June 30, 2010 at 5:42 pm By:
newswise Health News and Health Communicator
AMP Comments at FDA Meeting on Array-Based Tests: Today, the Association for Molecular Pathology (AMP) presented c... http://bit.ly/aJCXOz
Advertisement
MNT Drug Approvals
@mnt_drugapprov
AMP Comments At FDA Meeting On Array-Based Tests http://mnt.to/3FDb #regulatory
1 year ago...